Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy [Phase 2]

View source ↗

Summary

A phase 2 neoadjuvant trial evaluating atezolizumab-based combination therapy in men with localized prostate cancer prior to radical prostatectomy is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)

Snippet

Sponsor: David Oh | Conditions: Prostate Adenocarcinoma, Prostate Cancer | Phase 2 | Status: RECRUITING